An Exploratory Analysis Of Real-World Data For Assessing Patient Characteristics, Region, Stage, and PD-L1 Healthcare Utilization Among U.S. Patients With Advanced Lung Cancer
Hepatitis C Medications: Analysis of Adverse Drug Events and Poor Patient Outcomes
Calculating the costs of adverse drug reactions from post-marketing data: Implications for outcomes research
